Reason of Child Sex Offender Singer's Prison Demise Revealed
-
- By Jay Wilson
- 03 Oct 2026
Fewer than one in 10 individuals who could benefit from obesity jabs including Wegovy can access them, warns the WHO as it releases its first guidance on the drugs.
Considering in excess of 1,000,000,000 people worldwide currently obese, it is urging broader and more equitable availability to these injectable treatments.
Per estimates, in excess of 2,000,000,000 could be living with obesity by 2030 without intervention.
"The new guidelines affirms that excess weight is a lifelong illness that can be managed with comprehensive and lifelong support," remarked WHO director-general Tedros Adhanom Ghebreyesus.
Significant expense, insufficient output, and logistical bottlenecks are major hurdles to universal access to the treatments that can aid individuals in losing significant body mass, notes the organization.
Despite the present most optimistic scenario, the manufacturing of GLP-1 therapies could only cover approximately 100 million people – fewer than 10% of those who need them, as stated by the WHO.
The recommendation encourages countries and companies to widen access, by measures including licensing agreements.
The intellectual property rights on the active ingredient – the primary ingredient of the drug Wegovy – is scheduled to end in a number of nations in 2026.
These medications imitate a body's own hormone to reduce digestion speed, suppress the appetite and enhance satiety so individuals consume fewer calories.
Patients typically start to lose weight after several weeks of beginning the once-weekly jabs.
Research points to patients may regain a significant portion a year later of discontinuing the treatment, because their typical hunger come back.
Being carrying excess weight elevates your chance for contracting medical conditions, like type 2 diabetes, cardiovascular issues, brain attack, and some cancers.
Excess weight concerns individuals in countries worldwide and was linked to 3.7 million fatalities worldwide in 2024, per the health agency.
Astrophysicist and science communicator passionate about making complex space concepts accessible to everyone.